Current methods of staging and restaging of the mediastinal nodes in non-small-cell lung cancer

doi:10.5320/wjr.v5.i2.166

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7599)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

435

WORD

338

HTML

3642

Figures (1-1)

297

Tables (1-2)

219

Sum=4931

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1189

Download

1479

Sum=2668

Jul 28, 2015 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Respirology

ISSN

2218-6255

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Respirol. Jul 28, 2015; 5(2): 166-175
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.166

Table 1 Diagnostic yield of staging procedures in non-small-cell lung cancer (%)

Diagnostic technique	SensitivityMean (range)	SpecificityMean (range)	Negative predictive value Mean (range)
Chest CT	55 (20-91)	81 (50-97)	83 (54-97)
PET/CT	77 (33-100)	86 (43-100)	91 (79-100)
EBUS/TBNA	89 (46-97)	100 (96-100)	91 (60-99)
EUS/FNA	89 (45-100)	100 (90-100)	86 (68-100)
Mediastinoscopy	78 (32-92)	100	91 (80-97)
Video-mediastinoscopy	89 (78-97)	100	92 (83-96)
VATS	99 (58-100)	100	96 (88-100)
VAMLA	93.8	100	96
TEMLA	96.2	100	98.9

CT: Computer tomography; PET: Positron emission tomography; EBUS/TBNA: Endobronchial ultrasound/transbronchial needle aspiration; EUS/FNA: Endoscopic ultrasound/fine needle aspiration; VAMLA: Video-assisted mediastinoscopic lymphadenectomy; TEMLA: Transcervical extended mediastinal lymphadenectomy; VATS: Video-assisted thoracic surgery.

Table 2 Diagnostic yield of restaging procedures in non-small-cell lung cancer after neoadjuvant therapy (%)

Diagnostic technique	SensitivityMean (range)	SpecificityMean (range)	Negative predictive valueMean (range)
Chest CT	55 (20-91)	81 (50-97)	83 (54-97)
PET/CT	77 (33-100)	86 (43-100)	91 (79-100)
EBUS/TBNA	89 (46-97)	100 (96-100)	91 (60-99)
EUS/FNA	89 (45-100)	100 (90-100)	86 (68-100)
Mediastinoscopy	78 (32-92)	100	91 (80-97)
Video-mediastinoscopy	89 (78-97)	100	92 (83-96)
VATS	99 (58-100)	100	96 (88-100)
VAMLA	93.8	100	96
TEMLA	96.2	100	98.9

Citation: Zielinski M. Current methods of staging and restaging of the mediastinal nodes in non-small-cell lung cancer. World J Respirol 2015; 5(2): 166-175
URL: https://www.wjgnet.com/2218-6255/full/v5/i2/166.htm
DOI: https://dx.doi.org/10.5320/wjr.v5.i2.166